Gitelman syndrome |
SLC12A3
|
NCC |
Loss‐of‐function missense, nonsense, or frameshift‐introducing mutations in > 100 different positions along the protein, small deletions, mutations at donor and acceptor splice sites, etc. |
Autosomal recessive |
Impaired NCC activity due to impaired protein synthesis, increased cotransporter degradation, impaired trafficking to plasma membrane, impaired cotransporter function, etc. |
Acuna et al (2011), Gamba (2005), Sabath et al (2004) |
FHHt |
WNK1
|
WNK1 |
Deletions in intron 1 |
Autosomal dominant |
Ectopic L‐WNK1 expression in the DCT |
Vidal‐Petiot et al (2013), Wilson et al (2001) |
WNK1 |
Missense mutations in the acidic domain |
Autosomal dominant |
Decreased KS‐WNK1 degradation in the DCT |
Louis‐Dit‐Picard et al (2020) |
WNK4
|
WNK4 |
Missense mutations in the acidic domain |
Autosomal dominant |
Decreased WNK4 degradation in the DCT |
Brooks et al (2012), Golbang et al (2005), Gong et al (2008), Shibata et al (2013), Wakabayashi et al (2013), Wilson et al (2001) |
WNK4 |
Missense mutations in the C‐terminal regulatory region: R1185C and K1169E |
Autosomal dominant |
Disruption of inhibitory domain that promotes increased WNK4 activity |
Na et al (2012), Wilson et al (2001), Zhang et al (2011) |
KLHL3
|
KLHL3 |
Several missense mutations clustered in the BTB domain and specific regions of the kelch propeller domain |
Autosomal dominant |
Decreased WNK4 and KS‐WNK1 degradation in the DCT |
Boyden et al (2012), Louis‐Dit‐Picard et al (2012), Susa et al (2014), Susa et al (2017) |
KLHL3 |
Several loss‐of‐function missense, nonsense, and splicing‐altering mutations |
Autosomal recessive |
Decreased WNK4 and KS‐WNK1 degradation in the DCT |
Boyden et al (2012), Louis‐Dit‐Picard et al (2012), Sasaki et al (2017) |
CUL3
|
CUL3 |
Mutations that affect the splicing of exon 9 and result in an internal deletion of 57 amino acid residues in the protein |
Autosomal dominant |
Decreased WNK4 and KS‐WNK1 degradation in the DCT; impaired vascular relaxation through activation of RhoA‐ROCK pathway |
Abdel Khalek et al (2019), Boyden et al (2012), Ferdaus et al (2017), Ostrosky‐Frid et al (2020) |
SESAME / EAST syndrome |
KCNJ10
|
Kir4.1 |
Loss‐of‐function missense or nonsense mutations |
Autosomal recessive |
Impaired function of Kir4.1/Kir5.1 heterotetramers in the DCT leading to decreased basolateral K+ conductance |
Bockenhauer et al (2009), Scholl et al (2009), (Reichold et al (2010) |